Health
Vaccines for SARS coronavirus 2 and the new normal in vaccinology – Wiley
Click on the article title to read more.
Severe acute respiratory syndrome coronavirus 2 (SARSCoV2) causes an acute infection that is controlled by the immune response. The virus has a dominant surface protein that is highly immunogenic and it can be presumed that neutralising antibodies will prove to be the correlate of protection, supported by cellmediated immunity.1 It should therefore be straightforward to produce a vaccine against this novel virus.
This perspective has turned out to be true, but it is the pace with which the vaccines…
-
Noosa News22 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points
-
General24 hours agoUK names Sarah Mullally as first female Archbishop of Canterbury to lead Church of England
-
General24 hours agoSussan Ley responds to Andrew Hastie’s Shadow Cabinet resignation
-
General22 hours agoa pivotal moment in Liberal power struggle